Hedge-fund manager Boaz Weinstein isn’t backing down in his uphill battle against the $300 billion U.K. investment-trust ...

Some traders are betting regulators may soon focus on a review of the Supplementary Leverage Ratio (SLR), a rule requiring ...

The Trump administration's pledge to contain long-term U.S. Treasury yields has strengthened bond market expectations that a ...

Against all the odds, Boaz Weinstein is likely to lose all seven of the votes he demanded from the investment trust world. He ...

Deutsche Bank upgraded West Pharmaceutical (WST) to Buy from Hold with a price target of $250, down from $275. The company’s Q4 results and a ...

Deutsche Bank’s shift to Google Cloud powers up its AI capabilities, optimising operations and slashing process times ...

Deutsche Bank raised the firm’s price target on Applied Materials (AMAT) to $175 from $170 and keeps a Hold rating on the shares. The company ...

Investing.com - Steep federal government spending cuts, sizeable tariff revenues, and limited tax cuts could lead to a ...

Deutsche Bank Aktiengesellschaft assumed coverage on shares of Praxis Precision Medicines (NASDAQ:PRAX – Free Report) in a ...

Indian non-bank lender Shriram Finance has struck a US$500mn agreement with a group of banks and Italy’s export credit agency ...

Zillow Group (NASDAQ:Z – Free Report) had its target price increased by Deutsche Bank Aktiengesellschaft from $90.00 to ...

Deutsche Bank upgraded West Pharmaceutical Services (NYSE:WST) to Buy from Hold on Friday, even after the contract drug manufacturer witnessed a ~38% drop in the previous session following a ...